EUVIMEDEUVIMED entdecken
Open Access

Loss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinoma

Daien Zhou, Haoyang Yuan, Yiwei Hu, Chuxu Wang, S A Ge, Koufeng Shao, Hongying Wang, Xiaofeng Tian, Haibo Hu

Oncology Research · 2025

DOI: 10.32604/or.2024.050182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Daien Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, The Second People's Hospital of Huai'an, Huai'an, 22300…. Hauptthemen laut MEDLINE: Cisplatin, Adenocarcinoma of Lung, Drug Resistance, Neoplasm, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinAdenocarcinoma of LungDrug Resistance, NeoplasmLung NeoplasmsTWEAK ReceptorHumansCell Line, TumorCell ProliferationPrognosisAntineoplastic AgentsGene Expression Regulation, NeoplasticReactive Oxygen SpeciesNeoplastic Stem CellsA549 CellsFemaleMale

Stichwörter der Autor:innen

Cancer stem cells (CSCs)Cisplatin sensitivityLung cancerTNFRSF21

Substanzen

CisplatinTWEAK ReceptorAntineoplastic AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, The Second People's Hospital of Huai'an, Huai'an, 223001, China.
  • Medical Faculty, Kunming University of Science and Technology, Kunming, 650000, China.
  • The First School of Clinical Medicine, Nanjing Medical University, Nanjing, 210000, China.
  • Department of Oncology, Huai'an Chuzhou Hospital of Traditional Chinese Medicine, Zhongda Hospital Group Hospital Affiliated to Southeast University, Huai'an, 223001, China.

Zitieren

APA

Zhou, D., Yuan, H., Hu, Y., Wang, C., Ge, S. A., Shao, K., Wang, H., Tian, X., & Hu, H. (2025). Loss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinoma. Oncology Research. https://doi.org/10.32604/or.2024.050182

Vancouver

Zhou D, Yuan H, Hu Y, Wang C, Ge SA, Shao K, et al. Loss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinoma. Oncology Research. 2025. doi:10.32604/or.2024.050182

BibTeX
@article{Zhou2025,
  author = {Zhou, Daien and Yuan, Haoyang and Hu, Yiwei and Wang, Chuxu and Ge, S A and Shao, Koufeng and Wang, Hongying and Tian, Xiaofeng and Hu, Haibo},
  title = {Loss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinoma},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2024.050182}
}
Kostenlos starten →